Tumor suppressor ARF Antibody / CDKN2A / MLM | F54658-0.08ML

Tumor suppressor ARF Antibody / CDKN2A / MLM | F54658-0.08ML | Gentaur US, UK & Europe Disrtribition

Family: Primary antibody

Formulation: In 1X PBS, pH 7.4, with 0.09% sodium azide

Format: Purified

Clone: N/A

Host Animal: Rabbit

Clonality: Polyclonal (rabbit origin)

Species Reactivity: Human

Application: FACS, IHC-P, WB

Buffer: N/A

Limitation: This Tumor suppressor ARF antibody is available for research use only.

Purity: Antigen affinity purified

Description: This gene generates several transcript variants which differ in their first exons. At least three alternatively spliced variants encoding distinct proteins have been reported, two of which encode structurally related isoforms known to function as inhibitors of CDK4 kinase. The remaining transcript includes an alternate first exon located 20 Kb upstream of the remainder of the gene; this transcript contains an alternate open reading frame (ARF) that specifies a protein which is structurally unrelated to the products of the other variants. This ARF product functions as a stabilizer of the tumor suppressor protein p53 as it can interact with, and sequester, MDM1, a protein responsible for the degradation of p53. In spite of the structural and functional differences, the CDK inhibitor isoforms and the ARF product encoded by this gene, through the regulatory roles of CDK4 and p53 in cell cycle G1 progression, share a common functionality in cell cycle G1 control. This gene is frequently mutated or deleted in a wide variety of tumors, and is known to be an important tumor suppressor gene.

Immunogen: A portion of amino acids 72-101 from the human protein was used as the immunogen for the Tumor suppressor ARF antibody.

Storage: Aliquot the Tumor suppressor ARF antibody and store frozen at -20 °C or colder. Avoid repeated freeze-thaw cycles.